The mitochondria theory of aging proposes that accumulation of mitochondrial DNA (mtDNA) with pathogenic mutations, and the resultant respiration defects, are responsible not only for mitochondrial diseases but also for aging and age-associated disorders, including tumor development. This theory is partly supported by results obtained from our transmitochondrial mice (mito-mice), which harbor mtDNA with mutations that are orthologous to those found in patients with mitochondrial diseases: mito-mice express disease phenotypes only when they express respiration defects caused by accumulation of mutated mtDNA. With regard to tumor development, specific mtDNA mutations that induce reactive oxygen species (ROS) enhance malignant transformation of lung carcinoma cells to cells with high metastatic potential. However, age-associated respiration defects in elderly human fibroblasts are due not to mtDNA mutations but to epigenetic regulation of nuclear-coded genes, as indicated by the fact that normal respiratory function is restored by reprogramming of elderly fibroblasts.
Introduction
Because mitochondria are highly oxygenic organelles that produce ROS and because many chemical carcinogens have been shown to accumulate in mitochondria, mtDNA in mitochondria experiences stress of both endogenous ROS and exogenous chemical carcinogens. Therefore, the mitochondria theory of aging holds that mtDNA accumulates mutations much faster than does nuclear DNA, and the resultant respiration defects are responsible for the expression of mitochondrial diseases, aging, and age-associated 3 disorders [1] [2] [3] [4] [5] [6] . For example, the three most prevalent mitochondrial diseases (chronic progressive external ophthalmoplegia [CPEO] ); myoclonic epilepsy with ragged-red fibers [MERRF] ; and mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes [MELAS] ) are believed to be caused by mtDNA harboring a large-scale deletion (ΔmtDNA), a single point mutation in the tRNA Lys gene, and a single point mutation in the tRNA Leu(UUR) gene, respectively [1] [2] [3] . Moreover, in addition to their associations with mitochondrial diseases, these mtDNA mutations are hypothesized to be associated with human aging and age-associated disorders, including oncogenic transformation of normal cells to develop tumors. However, no convincing evidence for this hypothesis has yet been discovered.
Mito-mice as models for mitochondrial diseases and for gene therapy
Mitochondrial diseases that show maternal inheritance are considered to be due to mtDNA with pathogenic mutations that induce respiration defects upon their accumulation [1] [2] [3] .
However, we cannot exclude the possible involvement of nuclear abnormalities in the pathogenesis of these diseases. To confirm that mtDNA mutations are responsible for these diseases, we have to generate transmitochondrial mice (mito-mice) harbouring mtDNA with large-scale deletions (ΔmtDNA) or point mutations that are orthologous to those found in patients with mitochondrial diseases. These mice are effective for precise investigation of disease pathogenesis and for development of effective gene therapies for these diseases. 4 In previous studies [7, 8] , we generated mito-miceΔ, which harbor ΔmtDNA and therefore are disease models for CPEO, by transferring ΔmtDNA from a mouse cell line into the germline of female B6 mice. In addition, we recently generated new mito-mice that harbor mtDNA with a pathogenic G7731A mutation in the tRNA Lys gene (mito-mice-tRNA Lys7731 ), which may be useful as models for MERRF [9] . These mito-mice share the B6 nuclear background and express disease phenotypes only when respiration defects are induced by accumulation of mtDNA with pathogenic mutations [7] [8] [9] , suggesting that the mtDNA mutations are responsible for respiration defects and the resultant expression of abnormalities ( Fig. 1 ).
Mito-miceΔ have also been used for development of gene therapy in embryos [10] and in adult mice [11] . Because inheritance of mammalian mtDNA is strictly maternal (from mother to children) [12] , maternal transmission of mitochondrial diseases to progeny has been effectively prevented by the use of nuclear transplantation into enucleated zygotes of normal mice [10] . In adult mice, bone marrow transplantation from normal mice to mitomiceΔ has been shown to be effective for partial prevention of the expression of disease phenotypes [11] .
Subsequently, human embryos are used to perform nuclear transplantation from oocytes of one woman into enucleated oocytes from an unrelated woman for future prevention to We recently reported an alternative therapeutic strategy that does not use oocytes from unrelated women and instead uses oocytes from affected mothers [9] . MERRF model mice (mito-mice-tRNA Lys7731 ) show stochastic segregation of the heteroplasmic mtDNA (mtDNA with and without the mutation), and the resultant marked variation in the proportions of G7731A mtDNA among pups due to bottleneck effects [18] [19] [20] . Considering that abnormalities are not observed in mito-mice-tRNA Lys7731 with low proportions of G7731A mtDNA [9] , simple selection of oocytes with extremely low proportions of the mutated mtDNA from affected mothers likely would be sufficient to yield unaffected children (Fig. 2) .
Regulation of metastasis by mutations in mtDNA
Respiration defects and the resultant upregulation of glycolysis under normoxia enable cell growth under hypoxia and thus are thought to be involved in tumor development [21−24] .
Because pathogenic mtDNA mutations also induce upregulation of glycolysis under normoxia by inducing mitochondrial respiration defects, pathogenic mtDNA mutations or somatic mutations in mtDNA have been proposed to induce tumor development [1−3] .
If this proposal is correct, patients with mitochondrial diseases can be expected to preferentially develop tumors, because patients express upregulation of glycolysis under normoxia due to the pathogenic mutations in mtDNA. However, no statistical evidence for The effects of G13997A mtDNA on aging and tumor development in living mice can be examined by generating mito-mice-ND6 13997 , which carry the nuclear genome from B6 mice and G13997A mtDNA from B6-derived lung carcinoma cells [28] . Mito-mice-ND6 13997 do not express premature aging phenotypes and have a normal lifespan but show 7 lactic acidosis, hyperglycemia, and lymphoma development, indicating the possible involvement of mtDNA mutations in lymphoma development in B6 mice (Fig. 1) . However, considering that the B6 nuclear background is prone to lymphoma development, G13997A mtDNA might not develop lymphoma independently. By generating mito-mice with G13997A mtDNA and a nuclear background from the A/J strain mice, which are not prone to lymphoma development, we show that these mito-mice do not develop lymphoma [29] .
These results indicate that G13997A mtDNA simply enhances the frequency of lymphoma development, which is due primarily to abnormalities in the B6 nuclear genome.
Epigenetic regulation of human age-associated respiration defects
The mitochondrial theory of aging also holds that ROS overproduction and the resultant accumulation of somatic mutations in mtDNA are responsible for aging and age-associated respiration defects [1] [2] [3] [4] [5] [6] . This contention is supported partially by subsequent studies [30, 31] , which have generated mtDNA mutator mice expressing a proofreading-deficient mtDNA polymerase: mtDNA mutator mice show accelerated accumulation of somatic mutations in mtDNA due to the proofreading deficiency and the resultant expression of respiration defects and early-onset aging phenotypes. However, it appears controversial that mtDNA mutator mice do not show ROS overproduction [31] , and mito-mice-ND6 13997 overproducing ROS do not show early-onset aging phenotypes [28] . Moreover, one important question that has to be addressed is whether elderly human subjects really 8 accumulate such amounts of somatic mtDNA mutations as the mtDNA mutator mice do in their tissues.
Our previous studies have suggested the involvement of nuclear mutations in the ageassociated respiration defects found in elderly human fibroblasts, as indicated by experiments involving mtDNA transfer from elderly fibroblasts into mtDNA-less HeLa cells [32] and by experiments involving nuclear DNA transfer from mtDNA-less HeLa cells into elderly fibroblasts [33] . Because transfer of the nuclear genome from mtDNAless HeLa cells (that is, the nuclear genome uncontaminated by mtDNA) into elderly fibroblasts restores the respiration defects, these defects must be caused not by mtDNA mutations but by nuclear-recessive mutations [33] . However, our findings can also be explained by assuming the involvement of epigenetic regulation of nuclear genes in the absence of nuclear-recessive mutations.
The issue of whether age-associated respiration defects observed in elderly human subjects are due to mutations or to epigenetic changes is resolved by reprogramming of human fibroblasts [34] . First, we show that age-associated mitochondrial respiration defects are expressed in the absence of either ROS overproduction in the mitochondria or the accumulation of somatic mutations in mtDNA indicating that these aging phenotypes expressed in human fibroblasts are not caused by mtDNA mutations [34] . Moreover, when elderly fibroblasts are reprogrammed by the creation of induced pluripotent stem cells (iPSCs), reduced respiratory function is restored, suggesting that epigenetic-not geneticregulation confers these human aging phenotypes [34] . It is therefore likely that these ageassociated respiration defects are controlled neither by ROS overproduction nor by 9 mutations but rather by reversible epigenetic regulation of nuclear genes ( Figs. 1 and 3) . A recent study [35] proposes that reprogramming also recovers other aging phenotypes of human fibroblasts, such as abnormal mitochondrial metabolism, shortened telomeres, and limited proliferation capacities. Therefore, most age-related phenotypes in human fibroblasts are under epigenetic regulation.
The question then arises as to which nuclear genes cause age-associated mitochondrial respiration defects by means of epigenetic regulation? A microarray analysis has revealed that epigenetic downregulation of nuclear-coded genes, including GCAT and SHMT2, which regulate glycine production in mitochondria, results in respiration defects [34] .
Given that the age-associated respiration defects in elderly fibroblasts are likely due in part to reduced translation activity in the mitochondria [32, 33] , defects in glycine metabolism in the mitochondria as a result of a reduction in SHMT2 and GCAT expression would be partly responsible for the reduction in mitochondrial translation, resulting in the expression of age-associated respiration defects. For generalization of the concept that age-related phenotypes in human fibroblasts are under epigenetic regulation, further works are necessary to show whether epigenetic regulation of aging phenotypes are common to other human tissues.
Our major arguments are summarized in Fig. 1 . 
